Breaking News
July 21, 2018 - Parents say intense gun violence in PG-13 movies appropriate for teens 15 and older
July 21, 2018 - FAU researchers find possible cause of Parkinson’s disease in the patients’ immune system
July 21, 2018 - Protective qualities of ‘good cholesterol’ reduce after menopause
July 21, 2018 - Researchers develop new way to uncover hidden breast cancer tumors
July 21, 2018 - FDA approves first drug for treatment of adult AML patients with specific genetic mutation
July 21, 2018 - Top AI companies join hands to discover novel drugs for DMD
July 21, 2018 - Ferring announces FDA approval of ZOMACTON for injection in four new pediatric indications
July 20, 2018 - Researchers design proteins that can self-assemble into complex structures
July 20, 2018 - AVITA Medical expands management team to support launch of RECELL device to treat burns
July 20, 2018 - FDA Approves Tibsovo (ivosidenib) for Relapsed or Refractory Acute Myeloid Leukemia with an IDH1 Mutation
July 20, 2018 - Developmental screening and surveillance rates remain low, new study suggests
July 20, 2018 - TGen opens tissue donation portal to advance DIPG research
July 20, 2018 - Health impact of highly processed summertime staples
July 20, 2018 - Exergaming can improve health in overweight and obese children, study shows
July 20, 2018 - Postmenopausal factors may impact heart-protective qualities of ‘good cholesterol’
July 20, 2018 - MRI and blood test combination results in improved prostate cancer diagnosis
July 20, 2018 - Update Health Professional and Consumer on Recent Recalled Products
July 20, 2018 - Researchers trace Parkinson’s damage in the heart
July 20, 2018 - Wearable device designed to measure cortisol in sweat
July 20, 2018 - Scientists demonstrate a new regulation mechanism for skeletal muscles
July 20, 2018 - Exposure to mobile phone radiation may negatively impact memory performance in adolescents
July 20, 2018 - SUSU scientists find alternative method to treat post-traumatic stress disorder syndrome
July 20, 2018 - Gestational diabetes may increase offspring’s heart disease risk
July 20, 2018 - New vaccine could protect unborn babies from Zika virus
July 20, 2018 - Researchers find high mercury and methylmercury concentrations in traditional Tibetan medicine
July 20, 2018 - Brief Safety Plan Intervention in ER Can Cut Suicidal Behavior
July 20, 2018 - Toward a better understanding of Parkinson’s disease
July 20, 2018 - Med school communications office wins four national awards | News Center
July 20, 2018 - Professional baseball players with faster hand-eye coordination may have better batting performance
July 20, 2018 - Study looks into mechanisms that control sleep and wakefulness
July 20, 2018 - Scientists identify melanoma biomarkers that could help tailor immunotherapy treatments
July 20, 2018 - Research reveals long-term efficacy of drug used to treat common cause of kidney failure
July 20, 2018 - Timing of dinner associated with breast and prostate cancer risks
July 20, 2018 - Health Tip: Performing the Heimlich Maneuver
July 20, 2018 - Nearly all adolescents have eating, activity or weight-related issues
July 20, 2018 - Sage launches new web-based tool that helps explore curated genomic analyses of Alzheimer’s
July 20, 2018 - High-performance porous polymeric material for chromatography applications
July 20, 2018 - New molecule shows great promise for future treatment of many cancers
July 20, 2018 - New research project investigates alternative treatments for eye infections
July 20, 2018 - Immune T cells are built to react as fast as possible, shows study
July 20, 2018 - ZHX2 protein could offer a new treatment strategy for kidney cancer
July 20, 2018 - EKF’s Quo-Lab POC HbA1c analyzer meets international quality targets for diabetes testing
July 20, 2018 - Health burdens of very high risk drinking are potentially large, study reveals
July 20, 2018 - Using miniature drug-filled nanocarriers to target headaches and tumors
July 20, 2018 - Researchers uncover cause for progression of prostate cancer to incurable stage
July 20, 2018 - Studies highlight issues regarding black lung, opioid overdose, police violence and more
July 20, 2018 - AbbVie submits supplemental NDA to FDA for venetoclax to treat acute myeloid leukemia
July 20, 2018 - Researchers are one step closer to developing eye drops to treat age-related macular degeneration (AMD)
July 20, 2018 - Patients maintain muscle mass five years after surgically induced weight loss
July 20, 2018 - AMSBIO introduces new, powerful CRISPR/Cas9 gene editing kits
July 20, 2018 - PureTech Health collaborates with Roche to advance oral administration of antisense oligonucleotides
July 20, 2018 - Analysis reveals disparities in cancer death rates among minority groups
July 20, 2018 - Dr Maddy Parsons receives Royal Microscopical Society Life Science Medal
July 20, 2018 - Study finds link between DNA methylation and non-alcoholic fatty liver disease
July 20, 2018 - Military personnel with head trauma and football players with suspected CTE show similar brain changes
July 20, 2018 - Vidac Pharma Announces Initiation of Phase 2b Clinical Trial of VDA-1102 Ointment in Patients with Actinic Keratosis
July 20, 2018 - KKR is buying Envision Healthcare in a nearly $10B deal
July 20, 2018 - Older people with broken bones face higher risk of death for up to 10 years
July 20, 2018 - A simple pill for meth addicts on the cards
July 20, 2018 - UA researchers to repurpose ketamine to reduce side effects in Parkinson’s patients
July 20, 2018 - Child psychiatrist available on call to help assess separated immigrant children
July 20, 2018 - High bitter-taste sensitivity linked to increased risk of cancer
July 20, 2018 - Falling temperatures may lead to rise in numbers of deaths from stroke
July 20, 2018 - Supplemental oxygen prevents rise in morning blood pressure in OSA patients
July 20, 2018 - High fruit and vegetable intake linked to reduced risk of breast cancer
July 20, 2018 - Careful patient selection may help achieve good outcomes for vaginal mesh surgery
July 20, 2018 - Researchers raise viability of cloned mice using somatic cell nuclear transfer method
July 20, 2018 - 3HP for Latent TB Infection Treatment | 2018 | Newsroom | NCHHSTP
July 20, 2018 - An orange a day keeps macular degeneration away: 15-year study
July 20, 2018 - Researchers elucidate how the brain drives trial-by-trial adaptation to compensate for errors
July 20, 2018 - Understanding triple-negative breast cancer to develop better treatments
July 20, 2018 - Study compares outpatient antibiotic prescribing with traditional medical, retail clinic settings
July 20, 2018 - Immediate Monitoring With ECG Patch Ups A-Fib Diagnosis Rate
July 20, 2018 - KHN’s ‘What the Health?’ Drug prices and unicorns
July 20, 2018 - Scientists seek to better protect the eye from glaucoma
July 20, 2018 - Football training could improve bone mineral density in prostate cancer patients
July 20, 2018 - Single genetic change in gut bacteria can lead to obesity
July 20, 2018 - Research uncovers new target for therapeutic intervention in breast cancer
July 20, 2018 - WFN to highlight clean air for brain health on World Brain Day 2018
July 20, 2018 - Health Highlights: July 17, 2018
Psychiatric Drug Lithium Tied to Birth Defect Risk

Psychiatric Drug Lithium Tied to Birth Defect Risk

image_pdfDownload PDFimage_print

MONDAY, June 18, 2018 — Using the psychiatric drug lithium early in pregnancy may raise the risk of birth defects — but not as much as previously thought, a large new study suggests.

Researchers found that women who used lithium during the first trimester were more likely to have a baby with a birth defect, compared to pregnant women who had a mental health disorder but did not take lithium.

But the absolute risk was lower than previous studies had suggested, said researcher Dr. Veerle Bergink, a professor at the Icahn School of Medicine at Mount Sinai in New York City.

Birth defects affected slightly more than 7 percent of children born to moms who used lithium during the first trimester. That compared with just over 4 percent of children in the group not exposed to lithium.

Experts said the findings offer women and doctors more information to use in making treatment decisions.

Lithium was approved in the United States almost 50 years ago. It is mainly used to treat bipolar disorder — a mental health condition that causes severe shifts in mood, energy and ability to think clearly. People go through periods of depression and bouts of “mania,” where they feel elated, but may also become irritable, reckless and impulsive.

Close to 3 percent of Americans have bipolar disorder, according to the National Alliance on Mental Illness.

For people with the condition, Bergink said, lithium is considered the most effective medication for stabilizing mood.

However, she explained, its use has been limited in pregnant women and women who might become pregnant.

That’s because studies have linked the drug to a heightened risk of birth defects, such as malformations affecting the heart, particularly when it’s used in the first trimester.

But a “major challenge” in that kind of research is separating the effects of medication from any effects of the underlying mental health disorder, said Dr. Katherine Wisner, a perinatal psychiatrist and professor at Northwestern University in Chicago.

The new study compared women who used lithium in the first trimester with women who also had bipolar disorder or depression but did not use the drug. The goal was to zero in on the effects of lithium itself.

Wisner, who was not involved in the research, called the findings “welcome and long overdue.”

Wisner is a member of the Organization of Teratology Information Specialists. The group runs the MotherToBaby service, which provides research-based information on various pregnancy exposures.

The new findings are based on more than 22,000 women from six countries who gave birth between 1997 and 2015. All had a mood disorder — including bipolar disorder or depression — and 727 of them used lithium during the first trimester.

Overall, the study found, women on lithium did not have increased risks of any pregnancy or delivery complications.

But their babies were more likely to have a “major malformation” — such as heart defects, neural tube defects (such as spina bifida) and malformations of the penis.

Those risks, however, must be weighed against the risks of stopping lithium, Bergink and Wisner said.

“The risks associated with lithium treatment must be balanced with the risks of relapse for women who require this drug to treat bipolar disorder,” Wisner said. That relapse, she noted, may result in mania, depression, psychosis or self-harm.

Bergink said some options during pregnancy can include lowering the lithium dose, or going off the drug during the first trimester, then starting again — all done under medical supervision.

There are other medications for bipolar disorder. But they may carry pregnancy risks, too. The drug valproate (Depakote), for example, should not be used, Bergink said. It carries a significant risk of serious birth defects like spina bifida.

Antipsychotic medications are another option. The evidence shows they do not carry a birth defect risk, Bergink noted. But they are typically not as effective as lithium, she said.

The bottom line, said Bergink, is that women should talk to their doctors about their treatment options before they become pregnant.

“That way, you’ll have a good plan in place that will get you through your pregnancy,” she said.

Those one-on-one discussions are crucial, Wisner agreed. “Each woman brings her unique illness course and values to the decision-making,” she said.

The study findings were published online June 18 in The Lancet Psychiatry.

More information

The National Alliance on Mental Illness has more on bipolar disorder.

© 2018 HealthDay. All rights reserved.

Posted: June 2018

Tagged with:

About author

Related Articles